Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: Association with male predominance in mantle cell lymphoma

Haematologica

Volumn 93, Issue 6, 2008, Pages 949-950

  Nieländer, Inga ^a,h   Martín Subero, José I ^a   Wagner, Florian ^b,c   Baudis, Michael ^d   Gesk, Stefan ^a   Harder, Lana ^a   Hasenclever, Dirk ^e   Klapper, Wolfram ^a   Kreuz, Markus ^e   Pott, Christiane ^a   Martinez Climent, José A ^f   Dreyling, Martin ^g   Arnold, Norbert ^a   Siebert, Reiner ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b German Genome Resource Center RZPD   (Germany)

^c ATLAS BIOLABS GMBH   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f UNIVERSITY OF NAVARRA   (Spain)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Chromosome Y; Homozygous deletion; Mantle cell lymphoma; Pseudoautosomal region

Indexed keywords

ADULT; CANCER DIAGNOSIS; CARCINOGENESIS; CHROMOSOME ANALYSIS; CHROMOSOME DELETION Y; CHROMOSOME LOSS; GENE EXPRESSION; GENE MAPPING; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; KARYOTYPE; LETTER; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; PROSTATE CANCER; SEX DIFFERENCE; X CHROMOSOME;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, Y; FEMALE; HOMOZYGOTE; HUMANS; KARYOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MARKOV CHAINS; MIDDLE AGED; SEQUENCE DELETION; SEX FACTORS; TRANSLOCATION, GENETIC;

EID: 44949255184     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12656     Document Type: Letter

References (11)

1. Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005;131:29-38.
2. Anonymous. Loss of the Y chromosome from normal and neoplastic bone marrows. United Kingdom Cancer Cytogenetics Group (UKCCG). Genes Chromosomes Cancer 1992;5:83-8.
3. Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, et al. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization. Cancer Res 2006;66:4055-64.
4. Pyakurel P, Montag U, Castaños-Vélez E, Kaaya E, Christensson B, Tönnies H, et al. CGH of microdissected Kaposi's sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages. AIDS 2006;20:1805-12.
5. Martín-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA, et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002;98:470-4.
6. Rubio-Moscardo F, Climent J, Siebert R, Piris MA, Martín-Subero JI, Nieländer I, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 2005;105:4445-54.
7. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071-9.
8. Horwitz MS, Mealiffe ME. Further evidence for a pseudoautosomal gene for Hodgkin's lymphoma: Reply to 'The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database' by Altieri A and Hemminki K. Leukemia 2007;21:351.
9. Kremer E, Baker E, D'Andrea RJ, Slim R, Phillips H, Moretti PA, et al. A cytokine receptor gene cluster in the X-Y pseudoautosomal region? Blood 1993;82:22-8.
10. Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004;104:502-8.
11. Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001;15:752-6.